ArticleOpen forum infectious diseases2022

Safety and Efficacy of Tocilizumab 4 or 8 mg/kg in Hospitalized Patients With Moderate to Severe Coronavirus Disease 2019 Pneumonia: A Randomized Clinical Trial.

Princy N Kumar et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.